JP2018030858A5 - - Google Patents

Download PDF

Info

Publication number
JP2018030858A5
JP2018030858A5 JP2017178964A JP2017178964A JP2018030858A5 JP 2018030858 A5 JP2018030858 A5 JP 2018030858A5 JP 2017178964 A JP2017178964 A JP 2017178964A JP 2017178964 A JP2017178964 A JP 2017178964A JP 2018030858 A5 JP2018030858 A5 JP 2018030858A5
Authority
JP
Japan
Prior art keywords
compound
stereoisomer
following
compound according
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017178964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018030858A (ja
JP6572273B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018030858A publication Critical patent/JP2018030858A/ja
Publication of JP2018030858A5 publication Critical patent/JP2018030858A5/ja
Application granted granted Critical
Publication of JP6572273B2 publication Critical patent/JP6572273B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017178964A 2012-03-14 2017-09-19 Cgrp受容体アンタゴニストの製造方法 Active JP6572273B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261610746P 2012-03-14 2012-03-14
US61/610,746 2012-03-14
US201261644648P 2012-05-09 2012-05-09
US61/644,648 2012-05-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015500541A Division JP6212534B2 (ja) 2012-03-14 2013-03-13 Cgrp受容体アンタゴニストの製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019148465A Division JP6743256B2 (ja) 2012-03-14 2019-08-13 Cgrp受容体アンタゴニストの製造方法

Publications (3)

Publication Number Publication Date
JP2018030858A JP2018030858A (ja) 2018-03-01
JP2018030858A5 true JP2018030858A5 (enExample) 2018-05-10
JP6572273B2 JP6572273B2 (ja) 2019-09-04

Family

ID=49161940

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015500541A Active JP6212534B2 (ja) 2012-03-14 2013-03-13 Cgrp受容体アンタゴニストの製造方法
JP2017178964A Active JP6572273B2 (ja) 2012-03-14 2017-09-19 Cgrp受容体アンタゴニストの製造方法
JP2019148465A Active JP6743256B2 (ja) 2012-03-14 2019-08-13 Cgrp受容体アンタゴニストの製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015500541A Active JP6212534B2 (ja) 2012-03-14 2013-03-13 Cgrp受容体アンタゴニストの製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019148465A Active JP6743256B2 (ja) 2012-03-14 2019-08-13 Cgrp受容体アンタゴニストの製造方法

Country Status (11)

Country Link
US (1) US9487523B2 (enExample)
EP (1) EP2825044B1 (enExample)
JP (3) JP6212534B2 (enExample)
KR (7) KR20220164616A (enExample)
CN (1) CN104168768B (enExample)
AU (1) AU2013232196C1 (enExample)
BR (1) BR112014022542A8 (enExample)
CA (1) CA2865944C (enExample)
MX (1) MX346252B (enExample)
RU (1) RU2672056C2 (enExample)
WO (1) WO2013138418A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI501968B (zh) * 2010-11-12 2015-10-01 Merck Sharp & Dohme 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑
WO2013138413A1 (en) 2012-03-14 2013-09-19 Merck Sharp & Dohme Corp. Bis-quarternary cinchona alkaloid salts as asymmetric phase transfer catalysts
US9174989B2 (en) * 2012-05-09 2015-11-03 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists
US12168004B2 (en) 2014-02-05 2024-12-17 Merck Sharp & Dohme Llc Treatment of migraine
US10117836B2 (en) 2014-02-05 2018-11-06 Merck Sharp & Dohme Corp. Tablet formulation for CGRP active compounds
CN105037210A (zh) * 2015-05-27 2015-11-11 江苏大学 一种α,β-脱氢-α-氨基酸的合成方法
GB201707938D0 (en) 2017-05-17 2017-06-28 Univ Sheffield Compounds
US12383545B1 (en) 2018-06-08 2025-08-12 Allergan Pharmaceuticals International Limited Treatment of migraine
JP7690493B2 (ja) * 2020-05-04 2025-06-10 大鵬薬品工業株式会社 Iapアンタゴニスト化合物及びその中間体、並びにそれを合成する方法
MX2023001071A (es) 2020-07-29 2023-05-12 Allergan Pharmaceuticals Int Ltd Tratamiento de la migraña.
CA3206184A1 (en) 2020-12-22 2022-06-30 Allergan Pharmaceuticals International Limited Treatment of migraine
JP2024533756A (ja) 2021-09-27 2024-09-12 アラガン ファーマスーティカルズ インターナショナル リミテッド アトゲパントを含む片頭痛の併用療法
WO2024134683A1 (en) * 2022-12-21 2024-06-27 Msn Laboratories Private Limited, R&D Center Novel process for the preparation of intermediate compounds used in the treatment of migraine
CN117603205A (zh) * 2023-12-20 2024-02-27 杭州澳赛诺生物科技有限公司 一种奎尼丁衍生物手性相转移催化剂的合成方法及应用
CN119431222B (zh) * 2024-11-04 2025-10-17 杭州澳赛诺生物科技有限公司 一种不对称合成乌布吉泮手性中间体的方法
CN119350337A (zh) * 2024-12-24 2025-01-24 药康众拓(北京)医药科技有限公司 一类氘代哌啶酮酸酰胺氮杂茚满类cgrp抑制剂药物及用途
CN120398716A (zh) * 2025-04-17 2025-08-01 珠海奥博凯生物医药技术有限公司 一种基于连续流反应技术合成5-氰基-2-氟苯基化合物的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
ATE520661T1 (de) * 2003-06-27 2011-09-15 Univ Maryland Heterocyclische verbindungen mit quaternärem stickstoff zum nachweis von wässrigen monosacchariden in physiologischen flüssigkeiten
CN101124217A (zh) * 2004-01-29 2008-02-13 默克公司 Cgrp受体拮抗剂
EP1861399B1 (en) * 2005-03-14 2011-12-14 Merck Sharp & Dohme Corp. Cgrp receptor antagonists
WO2007133491A1 (en) * 2006-05-09 2007-11-22 Merck & Co., Inc. Substituted spirocyclic cgrp receptor antagonists
US7951795B2 (en) * 2006-12-08 2011-05-31 Merck Sharp & Dohme Corp. Constrained spirocyclic compounds as CGRP receptor antagonists
US8097750B2 (en) * 2006-12-20 2012-01-17 Brandeis University Cinchona alkaloid-catalyzed asymmetric mannich reactions
WO2008130524A1 (en) * 2007-04-16 2008-10-30 Merck & Co., Inc. Aryl heterocyclic cgrp receptor antagonists
CA2689217C (en) * 2007-06-05 2016-02-16 Merck & Co., Inc. Carboxamide heterocyclic cgrp receptor antagonists
JP5233457B2 (ja) * 2007-07-17 2013-07-10 セントラル硝子株式会社 新規な含フッ素ジカルボン酸およびそれを用いた新規な高分子化合物
KR101098335B1 (ko) * 2008-07-18 2011-12-26 성균관대학교산학협력단 신코나 기재 이작용성 유기 촉매 및 이를 이용한 메소-고리산무수물의 비대칭 고리 열림 반응을 통한 키랄성헤미에스터의 제조방법
AU2009283085A1 (en) * 2008-08-20 2010-02-25 Merck Sharp & Dohme Corp. Non-amidic linkers with branched termini as CGRP receptor antagonists
JP2012500783A (ja) * 2008-08-22 2012-01-12 エヴォテック・アクチエンゲゼルシャフト 新しいブラジキニンb1拮抗薬
EP2331101A4 (en) * 2008-09-08 2012-08-29 Merck Sharp & Dohme MONOCYCLIC AMID-CGRP RECEPTOR ANTAGONISTS
US8765763B2 (en) * 2009-06-05 2014-07-01 Boehringer Ingelheim International Gmbh Substituted piperazines as CGRP antagonists
WO2011005731A2 (en) * 2009-07-08 2011-01-13 Merck Sharp & Dohme Corp. Process for making cgrp receptor antagonist
US20120121508A1 (en) * 2009-07-27 2012-05-17 Merck Sharp & Dohme Corp. Radiolabeled cgrp antagonists
TWI501968B (zh) * 2010-11-12 2015-10-01 Merck Sharp & Dohme 六氫吡啶酮甲醯胺氮雜茚滿cgrp受體拮抗劑
WO2012064911A1 (en) 2010-11-12 2012-05-18 Merck Sharp & Dohme Corp. Piperidinone carboxamide indane cgrp receptor antagonists
WO2013138413A1 (en) 2012-03-14 2013-09-19 Merck Sharp & Dohme Corp. Bis-quarternary cinchona alkaloid salts as asymmetric phase transfer catalysts
US9174989B2 (en) 2012-05-09 2015-11-03 Merck Sharp & Dohme Corp. Process for making CGRP receptor antagonists

Similar Documents

Publication Publication Date Title
JP2019194236A5 (enExample)
JP2017008120A5 (enExample)
JP2018168171A5 (enExample)
JP2018024670A5 (enExample)
JP2020515557A5 (enExample)
JP2018521020A5 (enExample)
JP2018150298A5 (enExample)
JP2017514877A5 (enExample)
JP2017137500A5 (enExample)
JP2011527560A5 (enExample)
JP2017186358A5 (enExample)
JP2012111758A5 (enExample)
JP2009149903A5 (enExample)
JP2013532130A5 (enExample)
JP2017520128A5 (enExample)
JP2019124943A5 (enExample)
JP2014179090A5 (enExample)
JP2014235432A5 (enExample)
JP2018116258A5 (enExample)
JP2019519502A5 (enExample)
JP2018525542A5 (enExample)
JP2020528637A5 (enExample)
JP2016069397A5 (enExample)
JP2011037885A5 (enExample)
JP2022507958A5 (enExample)